跳至主要内容
临床试验/ACTRN12614000398606
ACTRN12614000398606已完成4 期

Corticosteroid, Autologous blood or Polidocanol injections guided by ultrasound in the management of tennis elbow: a randomised clinical pilot trial. (The CAP trial)

niversity of Queensland0 个研究点目标入组 45 人开始时间: 2014年4月11日最近更新:
适应症

试验速览

阶段
4 期
状态
已完成
发起方
入组人数
45

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Blinded (masking used)

入排标准

年龄范围
18 Years 至 75 Years(—)
性别
All

入选标准

  • Inclusion criteria is the presence of lateral elbow pain, which was exacerbated by activities involving wrist extension and gripping, as reported by the patient, as well as a clinical diagnosis of tennis elbow, which included elbow pain on resisted wrist and/or middle finger extension and tenderness in the area of the lateral epicondyle for more than two months.

排除标准

  • Exclusion criteria is elbow pain for less than two months, limitation of movement with passive forearm pronation, supination, flexion and/or extension that may indicate radioulnar joint synovitis or osteoarthritis, upper limb neurological symptoms or signs that may indicate cervical radiculopathy, and corticosteroid injection, autologous blood or scleosant injection to the common extensor tendon within the previous three months.
  • Patients meeting the inclusion and exclusion criteria above, will be referred for power Doppler ultrasound investigation.
  • Participants without evidence of neovascularisation on power ultrasound will be excluded from further participation in the study.

研究者

发起方
niversity of Queensland

相似试验